The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Concise Review: Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Acute Liver Failure and Cirrhosis
Open accessAbstract
Currently, the most effective therapy for acute liver failure and advanced cirrhosis is liver transplantation. However, this procedure has several limitations, including lack of donors, surgical complications, immunological suppression, and high medical costs. The alternative approaches that circumvent the use of a whole liver, such as stem cell transplantation, have been suggested as an effective alternate therapy for hepatic diseases. Mesenchymal stem cells (MSCs), also known as multipotent mesenchymal stromal cells, are self-renewing cells that can be found in almost all postnatal organs and tissues, including liver. During the past decade, great progress has been made in the field of MSC-dependent liver regeneration and immunomodulation. Because of their potential for differentiation into hepatocytes as well as their immunomodulatory characteristics, MSCs are considered as promising therapeutic agents for the therapy of acute liver failure and cirrhosis. In this concise review, we have summarized therapeutic potential of MSCs in the treatment of acute liver failure and cirrhosis, emphasizing their regenerative and immunomodulatory characteristics after engraftment in the liver. We have also presented several outstanding problems including conflicting data regarding MSCs engraftment in the liver and unwanted mesenchymal lineage differentiation in vivo which limits MSC therapy as a mainstream treatment approach for liver regeneration. It can be concluded that efficient and safe MSC-based therapy for acute and chronic liver failure remains a challenging issue that requires more investigation and continuous cooperation between clinicians, researchers, and patients. Stem Cells 2014;32:2818–2823
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492
Amer, M.-E. M., El-Sayed, S. Z., El-Kheir, W. A., Gabr, H., Gomaa, A. A., El-Noomani, N., & Hegazy, M. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283488b00 · Cited by 180
El-Ansary, M., Abdel-Aziz, I., Mogawer, S., Abdel-Hamid, S., Hammam, O., Teaema, S., & Wahdan, M. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9322-y · Cited by 179
Amin, M. A., Sabry, D., Rashed, L. A., Aref, W. M., el‐Ghobary, M. A., Farhan, M. S., Fouad, H. A., & Youssef, Y. A. (2013) · Clinical Transplantation · doi:10.1111/ctr.12179 · Cited by 88
Lin, N., Hu, K., Chen, S., Xie, S., Tang, Z., Lin, J., & Xu, R. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.007 · Cited by 61
Cited by
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.44 · Cited by 1,227
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
Mahla, R. S. (2016) · International Journal of Cell Biology · doi:10.1155/2016/6940283 · Cited by 604
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
Lou, G., Chen, Z., Zheng, M., & Liu, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.63 · Cited by 601
Effects of Oxidative Stress on Mesenchymal Stem Cell Biology
Denu, R. A., & Hematti, P. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2989076 · Cited by 333
Radiation-induced liver disease: current understanding and future perspectives
Kim, J., & Jung, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.85 · Cited by 260
Saeedi, P., Halabian, R., & Imani Fooladi, A. A. (2019) · Stem Cell Investigation · doi:10.21037/sci.2019.08.11 · Cited by 251
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71
Gazdic, M., Markovic, B. S., Arsenijevic, A., Jovicic, N., Acovic, A., Harrell, C. R., Fellabaum, C., Djonov, V., Arsenijevic, N., Lukic, M. L., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25049 · Cited by 65
Self-citationRoles of Macrophages and Exosomes in Liver Diseases
Shen, M., Shen, Y., Fan, X., Men, R., Ye, T., & Yang, L. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.583691 · Cited by 61
Fang, X., Liu, L., Dong, J., Zhang, J., Song, H., Song, Y., Huang, Y., Cui, X., Lin, J., Chen, C., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14081 · Cited by 53
Zhang, H., Siegel, C. T., Shuai, L., Lai, J., Zeng, L., Zhang, Y., Lai, X., Bie, P., & Bai, L. (2016) · Scientific Reports · doi:10.1038/srep21783 · Cited by 30
Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
Zhang, L.-T., Peng, X.-B., Fang, X.-Q., Li, J.-F., Chen, H., & Mao, X.-R. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3500 · Cited by 29
Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets
Itaba, N., Kono, Y., Watanabe, K., Yokobata, T., Oka, H., Osaki, M., Kakuta, H., Morimoto, M., & Shiota, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-43298-0 · Cited by 29
Qiao, H., Zhou, Y., Qin, X., Cheng, J., He, Y., & Jiang, Y. (2018) · Stem Cells International · doi:10.1155/2018/1239143 · Cited by 28
Jiang, C., Chen, H., Kang, Y., He, X., Huang, J., Lu, T., Sui, X., Chen, H., Xiao, J., Zhang, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01546-3 · Cited by 15
Cell therapy for end-stage liver disease: Current state and clinical challenge
Zhang, L., Deng, Y., Bai, X., Wei, X., Ren, Y., Chen, S., & Deng, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003332 · Cited by 12
Lai, J., Jiang, S., Shuai, L., Zhang, Y., Xia, R., Chen, Q., & Bai, L. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102477 · Cited by 12
Elberry, D. A., Amin, S. N., Esmail, R. S. E. N., Rashed, L. A., & Gamal, M. M. (2016) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2016-645 · Cited by 12
Metadata
- Authors
- Volarevic, V., Nurkovic, J., Arsenijevic, N., & Stojkovic, M.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-14
- Volume
- 32
- Issue
- 11
- Pages
- 2818-2823
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W1512831951
- Cited by
- 212
- References
- 5
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.